PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 closes lower for fourth day; Barclays shines

Thu, 27th Apr 2023 18:38

Unilever climbs on upbeat Q1 sales

*

Barclays rises after first-quarter profit

*

St. James Place drops on quarterly net flow miss

*

Capricorn Energy drops on FY operating loss

*

FTSE 100 0.3%, FTSE 250 up 0.2%

April 27 (Reuters) - Britain's FTSE 100 index closed lower for a fourth straight session on Thursday, weighed down by commodity-linked stocks although gains in banking shares following Barclays' upbeat results limited the decline.

Barclays jumped 5.3%, logging its best day in over a year after its profit in the first-quarter exceeded expectations, boosted by its credit card business in the United States.

The broader banking sector rose 1%.

"Markets want to hear good reports from banks and they got that from Barclays and they are awarding the company," said Steve Sosnick, chief strategist at Interactive Brokers.

"The bank is certainly putting some support under the whole FTSE 100 which is dragged down by energy stocks."

The blue-chip index fell 0.3% to 7,831.5 points, while the mid-cap FTSE 250 closed 0.2% up at 19,248 points.

The energy sector dropped 1.5% and precious metals miners shed 1% tracking lower commodity prices.

Market participants exercised caution this week, with investors on the lookout for clues on the impact of monetary tightening on company earnings and forecasts.

Investors also await the decision from major central banks in May amid looming recession worries.

The healthcare sector, comprising firms that rely on export earnings, shed 0.3% as the pound rose.

They included AstraZeneca Plc whose shares ended down 0.4% even though the company beat expectations for its first-quarter profit and revenue, helped by sales of its drugs in emerging markets.

St. James Place Plc fell 3.7% after the asset manager's quarterly net flows missed expectations amidst a challenging economic environment.

Unilever gained 1.4% after it smashed quarterly sales forecasts as another big rise in prices triggered only a small dip in volumes.

Capricorn Energy shed 10.3% dropping to the bottom of FTSE 250, after posting an annual operating loss of $160 million. (Reporting by Shristi Achar A and Johann M Cherian in Bengaluru; Editing by Sonia Cheema, Eileen Soreng and Susan Fenton)

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.